Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AVEO Pharmaceuticals Inc

+ Add to Watchlist

AVEO:US

1.1199 USD 0.0301 2.62%

As of 10:20:50 ET on 03/04/2015.

Company Profile for AVEO Pharmaceuticals Inc (AVEO)

Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.

Contact Information

AVEO Pharmaceuticals Inc

650 East Kendall Street
Cambridge, MA 02142
United States
Phone: 1-617-299-5000
Fax: 1-617-995-4995

Key Executives for AVEO Pharmaceuticals Inc (AVEO)

Jeno GyurisChief Executive OfficerMichael P BaileyPresident & CEO:Aveo Oncology
Joseph VittiglioSenior VP/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil